I-Mab Announces Givastomig Abstract Accepted For Oral Presentation At ESMO GI 2025
April 30 (Reuters) - I-Mab IMAB.O:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.